维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Flink H"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients 显示文摘	Buster EH Flink I-IJ Simsek H Heathcote FA Sharmila S Kitis GE Gerken G Buti M de Vries RA Verhey E Hansen BE Janssen HL	2009	Am J Gastroenterol2009，104，10：	1
	2	Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with pegintefferon alpha-2b 显示文摘	Buster EH Flink H J Cakaloglu Y	2008	Gastroenterology2008，135，2：	1
	3	Sustained HBeAg and HBsAg loss after long-term follow -up of HBeAg positive patients treated with peginterfern alpha- 2b 显示文摘	Buster E H Flink H J Cakaloglu Y	2008	Gastroenterology2008，135，2：	1
	4	Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon al- pha-2b显示文摘	Buster EH Flink H J Cakaloglu Y	2008	Gastroenterology2008，135，2：	1
	5	Intrinstic diffu- sion coefficient of interstitial copper in silicon 显示文摘	Istratov A A Flink C Hieslmair H er al	1998	Phys Rev Lett1998，81，6：	1
	6	Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon alpha-2b therapy 显示文摘	Flink H J Sprengers D Hansen B E	2005	Gut2005，54，11：	1
	7	The Safety of Pegylated Interferon Alpha-2b in the Treatment of Chronic Hepatitis B: Predictive Factors for Dose Reduction and Treatment Discontinuation显示文摘	Van Zonneveld M Flink H J Verhey E	2005	Aliment Pharmacol Ther2005，21，9：	1
	8	Sustained HBeAg and HBsAg loss after long -term follow up of HBeAg - positive patients treated with peginterferon a -2b显示文摘	BUSTER EH FLINK H J CAKALOGLU Y	2008	Gastro- enterology2008，135，2：	1
	9	Atrial and ventricular cardiac myosins contain different heavy chain species 显示文摘	Flink I L Rader J H Banerjee S K Morkin E	1978	FEBS Lett1978，94，：	1
	10	Influence of the time of measure- ment of unstimulated human whole saliva on the diagnosis of hypos- alivation显示文摘	Flink H Tegelberg A Lagerlof F	2005	Arch Oral Biol2005，50，6：	1
	11	Measurement of irreversible potential as a metallurgical tool 显示文摘	BROWN R H FLINK W L HUNTER M S	1941	Transactions of the American Institute of Metallurgical Engineers1941，143，：	1
	12	The safety of Peginterferon alfa-2b in the treatment of chronic hepatitis B 显示文摘	Van Zonnelveld M Flink H J Verhey E	2005	Aliment Pharmacol Ther2005，21，9：	1
	13	Influence of Interstitial Copper on Diffusion Length and Lifetime of Minority Carriers in p-type Silicon 显示文摘	Istratov A A Flink C Hielsmair H	1997	Applied Physics Letters1997，71，15：	1
	14	The safety of pegylated interferon alpha-2bin the treatment of chronic hepatitis B:predictive factors for dose reduction and treatment discontinuation显示文摘	van Zonneveld M Flink H J Verhey E HBV 99-01Study Group	2005	Aliment Pharmacol Ther2005，21，9：	1
	15	Formation of Copper Precipitates in Silicon 显示文摘	Flink C Feick H McHugo S A	1999	Physica B : Condensed Matter1999，，：	1
	16	Treatment with Peg - vinterferon alpha - 2b for HBeAg - positive chronic hepatitis B: HBsAg loss is associated with HBV genotype 显示文摘	Flink H J van Zonneveld M Hansen B E	2006	Am J Gastroentere12006，101，2：	1
	17	Early HBeAg loss during peginterferonα-2b therapy predicts HBsAg loss:Results of a long-term fol ow-up study in chronic hepatitis B patients显示文摘	Buster EH Flink HJ Simsek H		0，，10：	1
	18	High-dose magnesi- um sulfate attenuates pulmonary oxygen toxicity 显示文摘	FLINK E B DEDHIA H V DINSMORE J	1992	Crit Care Med1992，20，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费